Note: Single-source report; awaiting corroboration.
Health authorities in the Democratic Republic of the Congo have expanded isolation and treatment capacity for the rare Bundibugyo species of Ebola virus in the eastern regions, including constructing individual isolation rooms that meet the latest infection prevention standards and installing a 10,000-litre water tank to support patient care.
WHO Director-General Tedros Adhanom Ghebreyesus described community mistrust as a major obstacle to outbreak response efforts, noting that affected communities may feel the outside world prioritizes its own safety over their well-being. He also highlighted how insecurity, population displacement, and movement complicate the response in Ituri province, where the outbreak is concentrated. Tedros criticized broad travel restrictions as ineffective and potentially harmful.
Currently, there are no approved vaccines or treatments for Bundibugyo virus disease, though clinical trials for promising medicines are expected to begin in the near future. The WHO leader emphasized the need for long-term planning to prevent future outbreaks.
Alongside these developments, the WHO published its first comprehensive clinical management guidelines for all filovirus diseases, including Ebola and Marburg viruses. The guidelines offer 16 evidence-based recommendations focused on early supportive care such as rapid treatment of dehydration and shock, management of bacterial infections, laboratory monitoring, and structured survivor follow-up, which may improve survival rates in the absence of vaccines or treatments.
Tedros stressed that ending the outbreak will require strong community engagement, coordinated cross-border actions, and investments in broader health services to address other critical needs beyond Ebola.